Ambeed.cn

首页 / / / Gli / GANT61

GANT61 {[allProObj[0].p_purity_real_show]}

货号:A109328

GANT61 是一种 Gli1 和 Gli2 抑制剂,靶向 Hedgehog/GLI 通路。

GANT61 化学结构 CAS号:500579-04-4
GANT61 化学结构
CAS号:500579-04-4
GANT61 3D分子结构
CAS号:500579-04-4
GANT61 化学结构 CAS号:500579-04-4
GANT61 3D分子结构 CAS号:500579-04-4
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

GANT61 纯度/质量文件 产品仅供科研

货号:A109328 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

GANT61 生物活性

描述 GANT61 (20 μM) induces more significant cell death compared to targeting Smo (cyclopamine). It also inhibits the clonogenic survival of human colon carcinoma cell lines (0, 5, 10, 20 μM). Moreover, GANT61 (20 μM, 0-72 hr) downregulates Gli1 and Gli2 expression in HT29 cells. Additionally, GANT61 (0, 10 μM, or 20 μM) differentially regulates genes involved in the balance between cell death and survival[1]. GANT-61 inhibits cell viability and induces apoptosis in pancreatic CSCs. It also suppresses the expression of downstream targets of the Shh pathway, decreases Gli-DNA interaction, Gli transcriptional activity, and Gli nuclear translocation in pancreatic CSCs. Furthermore, GANT-61 modulates genes associated with cell survival, cell death, and pluripotency, while also inhibiting the motility, invasion, and migration of CSCs[2]. The sensitivity of GANT61 correlates positively with GLI1 and negatively with MYCN expression in the tested neuroblastoma cell lines. GANT61 downregulates the expression of GLI1, c-MYC, MYCN, and Cyclin D1, and induces apoptosis in neuroblastoma cells[3].
体内研究

Administered at a dose of 40 mg/kg via intraperitoneal injection three days per week, GANT-61 inhibits CSC tumor growth in NOD/SCID IL2Rγ null mice[2].

Furthermore, GANT61 (50 mg/kg, per oral) enhances the effects of chemotherapeutic drugs used in neuroblastoma treatment in an additive or synergistic manner. It also reduces the growth of established neuroblastoma xenografts in nude mice[3].

体外研究

GANT61 (20 μM) induces more significant cell death compared to targeting Smo (cyclopamine). It also inhibits the clonogenic survival of human colon carcinoma cell lines (0, 5, 10, 20 μM). Moreover, GANT61 (20 μM, 0-72 hr) downregulates Gli1 and Gli2 expression in HT29 cells. Additionally, GANT61 (0, 10 μM, or 20 μM) differentially regulates genes involved in the balance between cell death and survival[1].

GANT-61 inhibits cell viability and induces apoptosis in pancreatic CSCs. It also suppresses the expression of downstream targets of the Shh pathway, decreases Gli-DNA interaction, Gli transcriptional activity, and Gli nuclear translocation in pancreatic CSCs. Furthermore, GANT-61 modulates genes associated with cell survival, cell death, and pluripotency, while also inhibiting the motility, invasion, and migration of CSCs[2].

The sensitivity of GANT61 correlates positively with GLI1 and negatively with MYCN expression in the tested neuroblastoma cell lines. GANT61 downregulates the expression of GLI1, c-MYC, MYCN, and Cyclin D1, and induces apoptosis in neuroblastoma cells[3].

GANT61 细胞实验

Cell Line
Concentration Treated Time Description References
MCF7-Ctrl 10 µM 48 h Restores EMT marker expression, inhibits invasion Nat Commun. 2017 Jun 12;8:15773.
HMLER-Ctrl 10 µM 48 h Inhibits GLI signaling activation, reduces migration and invasion Nat Commun. 2017 Jun 12;8:15773.
AML cell lines 20 μM 24 h Induced apoptosis, resulting in approximately 30% of cells undergoing apoptosis J Hematol Oncol. 2017 Jan 21;10(1):26.
PANC-1 30 μM 3 days GANT61 had a more modest effect on the viability and sphere formation of PANC-1 cells, but still significantly reduced cell viability at 30 μM. Mol Cancer. 2016 Jun 27;15(1):49.
Capan-1 M9 20 μM 3 days Inhibition of the Hh pathway significantly reduced the expression of stem cell marker CD133 and sphere formation, demonstrating the suppression of CSC-like properties. GANT61 was more effective than the SMO inhibitor cyclopamine in reducing sphere formation and cell viability. Mol Cancer. 2016 Jun 27;15(1):49.
Human mesenchymal stem cells 10 μM 24-48 h To investigate the effect of GANT61 on mesenchymal stem cells from MPN patients and healthy donors, results showed that GANT61 significantly reduced the expression of α-SMA and Gli1, and induced apoptosis in MPN-MSCs. Cell Stem Cell. 2017 Jun 1;20(6):785-800.e8.
NCI-H1299 cells 10, 20, and 30 μM Inhibited the migration and invasion abilities of NCI-H1299 cells Acta Pharm Sin B. 2022 Oct;12(10):3877-3890.
HT29 cells 20 µM 72 h GANT61 induced accumulation of HT29 cells at G1/S and early S-phase, followed by entry into subG1, leading to cell death. Cancer Res. 2011 Sep 1;71(17):5904-14.
WB-F344 cells 2 μM 4 days Inhibition of Gli1 expression reduced the expression of KRT19 and Ki67, as well as proinflammatory cytokines including IL-6 and TNF-α, thereby suppressing the differentiation of HPCs into cholangiocytes. Theranostics. 2024 Mar 25;14(6):2379-2395.

GANT61 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Capan-1 M9 xenograft model Intraperitoneal injection 40 mg/kg 3 times a week for 25 days Combination treatment with GANT61 and the mTOR inhibitor rapamycin significantly inhibited tumor growth in the Capan-1 M9 xenograft model. Mol Cancer. 2016 Jun 27;15(1):49.
Mice Jak2(V617F)-induced myelofibrosis model Subcutaneous injection 50 mg/kg Every other day for 9 weeks To investigate the therapeutic effect of GANT61 on Jak2(V617F)-induced myelofibrosis, results showed that GANT61 significantly reduced the number of Gli1+ cells, inhibited the development of bone marrow fibrosis, and improved splenomegaly and hemoglobin levels. Cell Stem Cell. 2017 Jun 1;20(6):785-800.e8.
BALB/c nude mice NSCLC metastasis model Intraperitoneal injection 50 mg/kg Every two days for a total of 30 days GANT-61 significantly suppressed the lung and liver metastasis of NSCLC Acta Pharm Sin B. 2022 Oct;12(10):3877-3890.
Mice Breast cancer xenograft model Subcutaneous injection 50 mg/kg Every other day for 18 days Inhibits metastasis and growth of non-EMT cells Nat Commun. 2017 Jun 12;8:15773.
Mice Unilateral ureteral obstruction model Subcutaneous injection 50 mg/kg Administered on days 1, 2, 3, 5, 7, and 9 after surgery GANT61 reduced renal fibrosis by decreasing GLI1 and GLI2 protein levels. J Clin Invest. 2015 Aug 3;125(8):2935-51
Nude mice NSCLC xenograft model Intraperitoneal injection 50 mg/kg Every other day for 24 days To evaluate the effect of GANT61 on tumor angiogenesis and tumor growth in NSCLC, the results showed that GANT61 significantly inhibited tumor angiogenesis and tumor growth. J Exp Clin Cancer Res. 2024 Mar 16;43(1):83

GANT61 动物研究

Dose Nude Mice: 25 mg/kg[3] (s.c.), 50 mg/kg[4] (p.o.)
Administration s.c., p.o.

GANT61 参考文献

[1]Mazumdar T, et al. Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Res. 2011 Feb 1;71(3):1092-102.

[2]Fu J, et al. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. Cancer Lett. 2013 Mar 1;330(1):22-32.

[3]Wickstrom M, et al. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Int J Cancer. 2013 Apr 1;132(7):1516-24.

GANT61 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.33mL

0.47mL

0.23mL

11.64mL

2.33mL

1.16mL

23.28mL

4.66mL

2.33mL

GANT61 技术信息

CAS号500579-04-4
分子式C27H35N5
分子量 429.6
SMILES Code CN(C)C1=CC=CC=C1CN2C(C3=CC=NC=C3)N(CC4=CC=CC=C4N(C)C)CCC2
MDL No. MFCD14635408
别名
运输蓝冰
InChI Key KVQOGDQTWWCZFX-UHFFFAOYSA-N
Pubchem ID 421610
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, store in freezer, under -20°C

溶解方案

DMSO: 25 mg/mL(58.19 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

无水乙醇: 60 mg/mL(139.66 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
方案 四
方案 五
方案 六
方案 七
方案 八
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。